Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : The Stock for 1999(Polymedica)PLMD(Medical Supply Co.) -- Ignore unavailable to you. Want to Upgrade?

To: Sam who wrote (2601)	5/4/1999 9:05:00 AM
From: Dan O.	Read Replies (1) \| Respond to of 3414

Tuesday May 4, 8:31 am Eastern Time Company Press Release PolyMedica Announces New Top Management Team At Liberty Medical Supply Subsidiary W. Keith Trowbridge Named President, Les Capella Appointed Sr. VP Business Development WOBURN, Mass.--(BUSINESS WIRE)--May 4, 1999--PolyMedica Corporation (Nasdaq:PLMD - news) today announced expansion of the senior management team at the Company's Liberty Medical Supply, Inc. subsidiary, the leading direct-to-patient provider of diabetes testing supplies to seniors. Liberty Medical has the largest proprietary database of Medicare eligible diabetics in the US and contributes 75% of PolyMedica's sales. W. Keith Trowbridge is the new President of Liberty Medical and was also elected Vice President of PolyMedica Corporation. Prior to joining PolyMedica, Mr. Trowbridge was President of U.S. Operations for Transworld Healthcare, Inc., a $300 million international company, where he presided over the success and profitability of three domestic operating units including MK Diabetes Support Services. Earlier, he was CEO of a national integrated network of physician owned pharmacies and held senior management posts at a number of healthcare companies. Mr. Trowbridge graduated from George Mason University in 1975 with a degree in Business Administration. Les Capella was appointed Senior Vice President, Business Development/Marketing, a new senior management position. He joined Liberty from Transworld Healthcare where he was Executive Vice President for Sales of the three U.S. operating units which included MK Diabetes Support Services. Earlier, he was the founder and COO of Precision Healthcare, Inc. a medical device company that became an industry leader and was sold in 1995 to Transworld Healthcare. Mr. Capella graduated from St. Joseph's University in 1982 with a Masters Degree in Health Care Administration. Commenting on the appointments, Steven J. Lee, Chairman and CEO of PolyMedica Corporation, said, ''Keith Trowbridge and Les Capella bring the extensive operating and marketing experience needed to continue the rapid and profitable expansion of Liberty Medical. Their leadership will capitalize on Liberty's extensive proprietary database and advanced proprietary customer service systems -- a major platform for further growth in diabetes and expansion into related direct-to-consumer categories. '' PolyMedica is best known through its subsidiaries and product lines. The Company's Liberty Medical Supply, Inc. subsidiary is the leading direct mail provider of diabetes testing supplies to seniors who have Medicare coverage. Liberty offers approximately 200 brand-name products from a full range of manufacturers. The Company's AZO line of products has a 45% share of the over-the-counter female urinary tract discomfort market. PolyMedica also is the leading manufacturer and distributor of private-label digital thermometers and has the number two overall market position in thermometers. For more information, please visit PolyMedica's web site at www.polymedica.com. This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from those anticipated. Such risks and uncertainties include, but are not limited to, changes in Medicare reimbursement, fluctuations in customer demand, management of rapid growth, intensity of competition from other healthcare product vendors, timing and acceptance of new product introductions, general economic conditions and regulatory changes, as well as other especially relevant risks detailed in the Company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended March 31, 1998, its Quarterly Report on Form 10-Q for the periods ended June 30, September 30, and December 31, 1998, and the information set forth herein should be read in light of such risks. The Company assumes no obligation to update the information contained in this press release. -------------------------------------------------------------------------------- Contact: PolyMedica Corporation Eric G. Walters, 781/933-2020 or VMW, Inc. Sylvia A. Dresner, 212/616-6161 VMWinc@banet.net